Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States.

"CONFLICT OF INTEREST MG reports a consulting/advisory role with Genentech, Bristol-Myers Squibb, Merck, AstraZeneca, EMD-Serono, Pfizer, and Astellas and research funding from Merck and Bristol-Myers Squibb; SP reports a consulting/advisory role with Genentech, Pfizer, Novartis, Exelixis, Ipsen, and Astellas; S-WL, SO, JS, CD, and CS report employment with Genentech/Roche, including stock; MZ reports a consulting/advisory role with Genentech; CD also reports travel sponsored by Genentech/Roche; CS also reports employment with Genentech/Roche, including stock, by a family member; GS reports a consulting/advisory role with Pfizer, Genentech, Novartis, Argos, Merck, Sanofi, Agensys, AstraZeneca, UpToDate, Biotheranostics, Exelixis, Bristol-Myers Squibb, Janssen, Amgen, Eisai, and National Comprehensive Care Network and research funding from Boehringer-Ingelheim, Bayer, Onyx-Amgen, Pfizer, Merck, and Celgene."

"FUNDING This study was sponsored by F. Hoffmann-La Roche, Ltd. Medical writing assistance for this manuscript was provided by Eric Berlin, MD, of Health Interactions, Inc (San Francisco, CA), and was funded by F. Hoffmann-La Roche."